- Report
- April 2023
- 120 Pages
Global
From €4241EUR$4,750USD£3,701GBP
- Training
- 60 Minutes
Global
- Training
- 60 Minutes
Global
- Report
- August 2022
- 541 Pages
Global
From €2232EUR$2,500USD£1,948GBP
- Report
- July 2022
- 518 Pages
Global
From €1785EUR$2,000USD£1,558GBP
- Report
- April 2022
- 413 Pages
Global
From €2232EUR$2,500USD£1,948GBP
- Report
- August 2022
- 151 Pages
Global
From €3125EUR$3,500USD£2,727GBP
- Report
- November 2021
- 1032 Pages
Global
From €4464EUR$5,000USD£3,896GBP
- Book
- April 2022
- 480 Pages
- Book
- April 2020
- 608 Pages
- Book
- June 2019
- 496 Pages
- Book
- May 2018
- 1064 Pages
- Book
- December 2010
- 800 Pages
- Book
- March 2010
- 784 Pages
Translational Medicine is a field of biotechnology that focuses on the development of treatments and therapies for diseases and medical conditions. It involves the translation of basic research findings into clinical applications, such as the development of new drugs, diagnostics, and medical devices. Translational Medicine also involves the development of new methods for clinical trials and the evaluation of existing treatments.
The Translational Medicine market is driven by the need for new treatments and therapies for diseases and medical conditions. It is also driven by the need for improved diagnostics and medical devices. The market is expected to grow as new treatments and therapies are developed and as existing treatments are evaluated.
Some companies in the Translational Medicine market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more
